Website

Contact Information:

Julie Nelson
Julie.Nelson@morphosys.com
857-283-3783

Virtual Exhibit Hall Home

Founded in 1992 in Germany, MorphoSys is dedicated to making innovative biopharmaceuticals to help patients suffering from serious diseases. Based on its leading expertise in antibody, protein and peptide technologies, MorphoSys has developed and contributed to the development of more than 100 product candidates, 27 of which are currently in clinical development.

MorphoSys is headquartered in Planegg, Germany. In 2019, the US head office was established in Boston.

US Website: www.morphosys-us.com

MorphoSys US Inc.
470 Atlantic Avenue, Suite 1401, Boston, MA 02210, USA
E-mail: info.us@morphosys.com (US-specific requests)

Additional Information: 

MONJUVI® (tafasitamab-cxix) PI & Patient Information
Dosage and Administration Guide
HCP Brochure
MONJUVI MOA Animation